Click to copy
Click to copy

Coherus BioSciences: 2Q Earnings Snapshot

August 1, 2019

REDWOOD CITY, Calif. (AP) _ Coherus BioSciences Inc. (CHRS) on Thursday reported second-quarter net income of $23.6 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Redwood City, California-based company said it had profit of 32 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.

The drug developer posted revenue of $83.4 million in the period.

Coherus BioSciences shares have climbed 88% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $17.03, a drop of roughly 9% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS

All contents © copyright 2019 The Associated Press. All rights reserved.